✦ LIBER ✦

Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation

✍ Scribed by Aaron R. Sasson; Barbara Fowble; Alexandra L. Hanlon; Michael H. Torosian; Gary Freedman; Marcia Boraas; Elin R. Sigurdson; John P. Hoffman; Burton L. Eisenberg; Arthur Patchefsky

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 84 KB
Volume: 91
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20010515)91:10<1862::aid-cncr1207>3.0.co;2-#

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The relation between the presence and ex

The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy

✍ Anthony L. Abner; James L. Connolly; Abram Recht; Bruce Bornstein; Asa Nixon; St 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

## Background: When found in an otherwise benign biopsy, lobular carcinoma in situ (lcis) has been associated with an increased risk of development of a subsequent invasive breast carcinoma. however, the association between lcis and the risk of subsequent local recurrence in patients with infiltrat

Salvage treatment for local recurrence a

Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast

✍ Lawrence J. Solin; Alain Fourquet; Frank A. Vicini; Bruce Haffty; Marie Taylor; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

Long term follow-up of women with ductal

Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery : The effect of age

✍ Kimberly J. Van Zee; Laura Liberman; Billur Samli; Katherine N. Tran; Beryl McCo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

## BACKGROUND. Although in recent years there has been a dramatic increase in both the incidence of ductal carcinoma in situ (DCIS) and breast-conserving therapy for patients who have this disease, the optimal treatment for these patients remains controversial. Most data regarding outcomes have co